MedPath

Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBD

Conditions
Inflammatory Bowel Diseases
Interventions
Other: Psychometric validation of the questionnaire
Registration Number
NCT04180345
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD) are chronic disabling conditions characterized by flares followed by periods of remission. However, IBD patients are seen every 3 to 6 months in the outpatient clinic, and the occurrence of a flare between two outpatient visits is not captured. In the current state of knowledge, there is no validated patient-reported outcome (PRO) tool to measure the phenomenon of flare in IBD. This study aimed to use an innovative methodology to collect messages posted by patients in an Internet forum for developing and validating a PRO measuring flare in IBD.

The design involves 1) Engineering sciences for scraping extraction of messages posted in an Internet forum and for Identification of messages related to flare, 2) Qualitative methods for thematic content analyze of the messages posted, for candidate items generation, for items selection (Delphi process) and for items adjustment ("think aloud" interviews), 3) Quantitative methods for psychometric validation of the PRO.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Every patient consulting the gastroenterology unit of Nancy University Hospital with a confirmed IBD diagnosis, regardless of the patient's state or treatment will be considered for inclusion
Exclusion Criteria
  • patients with a diagnosis < 3 months.
  • Protected persons (minors, adults under guardianship, pregnant or breastfeeding women, people living in a public health or social institution, patients in an emergency situation, incarcerated individuals)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Validation of the questionnairePsychometric validation of the questionnaireItems reduction, ajustment and psychometric validation of the questionnaire
Primary Outcome Measures
NameTimeMethod
Scale calibration of the new developped questionnaireAbout 30 minutes

Weighing scale calibration

Construct validity of the new developped questionnaireAbout 30 minutes

Exploratory factor analysis, discriminant validity by Kruskal-Wallis tests

Convergence proprieties of the new developped questionnaireabout 30 minutes

Convergence test of Flare-IBD scores with objective biological markers and clinical markers used in routine clinical practice

Reproductibility of the new developped questionnaireUp to 8 days

Investigation of test-retest reliability with a second questionnaire administered 8 days later.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath